PHARMASOFT LTD

Company number 08111550 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£50k -£25k £0 £25k £50k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £32,283 Total assets 2017: £37,636 Total assets 2018: £10,087 Total assets 2019: £19,115 Total assets 2020: £42,654 Total assets 2021: £30,702 Total assets 2022: £48,396 Total assets 2023: £11,921 Total assets 2024: £1,772 Total assets 2025: £1,336 Total assets Net assets 2016: £12,486 Net assets 2017: £18,005 Net assets 2018: £155 Net assets 2019: £159 Net assets 2020: £2,497 Net assets 2021: £523 Net assets 2022: £14,599 Net assets 2023: £133 Net assets 2024: -£20,659 Net assets 2025: -£40,099 Net assets Total liabilities 2016: -£20,211 Total liabilities 2017: -£19,031 Total liabilities 2018: -£9,162 Total liabilities 2019: -£18,086 Total liabilities 2020: -£39,007 Total liabilities 2021: -£28,889 Total liabilities 2022: -£32,507 Total liabilities 2023: -£24,167 Total liabilities 2024: -£19,905 Total liabilities 2025: -£25,582 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 1 1 2 2 3 2024 2025 2024: 3 2025: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-06-30): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-06-30 £1,336 -£25,582 -£40,099 2
2024-06-30 £1,772 -£19,905 -£20,659 3
2023-06-30 £11,921 -£24,167 £133
2022-06-30 £48,396 -£32,507 £14,599
2021-06-30 £30,702 -£28,889 £523
2020-06-30 £42,654 -£39,007 £2,497
2019-06-30 £19,115 -£18,086 £159
2018-06-30 £10,087 -£9,162 £155
2017-06-30 £37,636 -£19,031 £18,005
2016-06-30 £32,283 -£20,211 £12,486 £20,463
2015-06-30 £100,795 -£24,885 £76,356 £100,795
2014-06-30 £72,363 -£26,946 £45,975 £65,643
2013-06-30 £22,358 -£13,595 £9,089 £12,758

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.